Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
for
Hemophilia A
Location: Minneapolis MN, Iowa City IA, Indianapolis IN,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416604
Phase 3, Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Minneapolis MN, Fairway KS, Detroit MI, Grand Rapids MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Minneapolis MN, West Dundee IL, Chicago IL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Minneapolis MN, Iowa City IA, Milwaukee WI, St Louis MO,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 17
Code: NCT06651580
Recruiting
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
for
Fibrosing Interstitial Lung Disease
Location: Minneapolis MN, Aurora CO, Boston MA
Sponsor: Boehringer Ingelheim
Sex: All
Age: 2 - 17
Code: NCT07366034
Phase 3, Recruiting
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
for
Hypochondroplasia
Location: Minneapolis MN, Chicago IL, Columbia MO,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0 - 3
Code: NCT07126262
Phase 2, Recruiting
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants